ClinConnect ClinConnect Logo
Search / Trial NCT06367959

Health Benefits of Writing Therapy Among Asian American Cancer Survivors

Launched by M.D. ANDERSON CANCER CENTER · Apr 11, 2024

Trial Information

Current as of August 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring how writing therapy can help Asian American cancer survivors, particularly those who have faced breast cancer. The researchers want to understand the experiences of these individuals and see if writing about their feelings and journeys can improve their health and well-being. The study is currently looking for participants, specifically Asian American adults aged 18 and older who have been diagnosed with certain stages of cancer and have completed their primary treatment within the last five years.

To be eligible, participants need to identify as Asian or Asian American and should be comfortable reading in English or Chinese. Those who choose to take part can expect to engage in writing exercises that allow them to express their thoughts and experiences related to their cancer journey. This trial not only aims to support participants through their healing process but also hopes to gather valuable insights that could help other survivors in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult (aged 18 and older) diagnosed with stage 0-III cancer (or acute leukemia in remission/ chronic myeloid leukemia in chronic phase).
  • Self-identified as Asian, Asian Americans, any Asian or Asian American subgroup (Chinese, Vietnamese, Indian, Korean, etc.) ethnic/cultural background
  • Completed primary treatment, including surgery, chemotherapy, and/or radiation therapy, immunotherapy, or targeted therapy within the preceding 5 years.
  • Comfortable reading in English or in Chinese.
  • Exclusion Criteria:
  • - Inability to provide informed consent.

About M.D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.

Locations

Houston, Texas, United States

Patients applied

AR

1 patients applied

Trial Officials

Qian Lu, MD, PHD

Principal Investigator

M.D. Anderson Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported